{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:46Z","timestamp":1791928966803,"version":"4.3.4"},"reference-count":52,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,1,21]]},"DOI":"10.1167\/iovs.67.1.47","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:00:46Z","timestamp":1769004046000},"page":"47","source":"Crossref","is-referenced-by-count":2,"title":["Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype"],"prefix":"10.1167","volume":"67","author":[{"given":"Kangjia","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Peng","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeyu","family":"Li","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Yao","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhou","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dong","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[{"name":"Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Stacy","sequence":"additional","affiliation":[{"name":"Translational Medicine \u2013 Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma'en","family":"Obeidat","sequence":"additional","affiliation":[{"name":"Translational Medicine \u2013 Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"China Novartis Institutes for BioMedical Research, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China"},{"name":"Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"10467","key":"bib1","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"bib3","doi-asserted-by":"publisher","first-page":"e45264","DOI":"10.1371\/journal.pone.0045264","article-title":"Prevalence of diabetic retinopathy in mainland China: a meta-analysis","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"bib4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1600-0420.1996.tb00727.x","article-title":"Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control","volume":"74","author":"Henricsson","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"bib5","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1038\/s41467-023-39864-w","article-title":"Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China","volume":"14","author":"Hou","year":"2023","journal-title":"Nat Commun"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14712598.2023.2247987","article-title":"The evolving therapeutic landscape of diabetic retinopathy","volume":"23","author":"Shughoury","year":"2023","journal-title":"Expert Opin Biol Ther"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1056\/NEJMra1909637","article-title":"Evaluation and care of patients with sdabetic retinopathy","volume":"382","author":"Jampol","year":"2020","journal-title":"N Engl J Med"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/metabo13121204","article-title":"Explainable artificial intelligence paves the way in precision diagnostics and biomarker discovery for the subclass of diabetic retinopathy in type 2 diabetics","volume":"13","author":"Yagin","year":"2023","journal-title":"Metabolites"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1218442","DOI":"10.3389\/fendo.2023.1218442","article-title":"Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study","volume":"14","author":"Si","year":"2023","journal-title":"Front Endocrinol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/IAE.0b013e31819a5fc2","article-title":"Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy","volume":"29","author":"Cho","year":"2009","journal-title":"Retina"},{"issue":"39","key":"bib12","doi-asserted-by":"publisher","first-page":"e34856","DOI":"10.1097\/MD.0000000000034856","article-title":"Efficacy and safety of pan retinal photocoagulation combined with intravitreal anti-VEGF agents for high-risk proliferative diabetic retinopathy: a systematic review and meta-analysis","volume":"102","author":"Fu","year":"2023","journal-title":"Medicine"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s40001-024-01847-y","article-title":"Deciphering M\u00fcller cell heterogeneity signatures in diabetic retinopathy across species: an integrative single-cell analysis","volume":"29","author":"Deng","year":"2024","journal-title":"Eur J Med Res"},{"issue":"13","key":"bib14","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.3390\/ijms22137142","article-title":"The vitreous ecosystem in diabetic retinopathy: insight into the patho-mechanisms of disease","volume":"22","author":"Iyer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1178641816686078","DOI":"10.1177\/1178641816686078","article-title":"Characterization of vitreous and aqueous proteome in humans with proliferative diabetic retinopathy and its clinical correlation","volume":"8","author":"Balaiya","year":"2017","journal-title":"Proteomics Insights"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1021\/pr800112g","article-title":"Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy","volume":"7","author":"Gao","year":"2008","journal-title":"J Proteome Res"},{"issue":"19","key":"bib17","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.3390\/ijms20194755","article-title":"Proteomic biomarkers of retinal inflammation in diabetic retinopathy","volume":"20","author":"Youngblood","year":"2019","journal-title":"Int J Mol Sci"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12886-018-0821-3","article-title":"Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"499","key":"bib19","doi-asserted-by":"publisher","first-page":"eaau6627","DOI":"10.1126\/scitranslmed.aau6627","article-title":"Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy","volume":"11","author":"Yokomizo","year":"2019","journal-title":"Sci Transl Med"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1021\/acs.jproteome.5b00900","article-title":"Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients","volume":"14","author":"Loukovaara","year":"2015","journal-title":"J Proteome Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1074\/mcp.M600162-MCP200","article-title":"Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications","volume":"5","author":"Qian","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"bib22","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"W1","key":"bib23","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"bib24","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12886-020-01688-3","article-title":"Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients","volume":"20","author":"Liao","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"bib27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/aos.13325","article-title":"Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases","volume":"96","author":"Nguyen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.survophthal.2021.06.002","article-title":"Use of erythropoietin in ophthalmology: a review","volume":"67","author":"Feizi","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"bib29","doi-asserted-by":"publisher","first-page":"18810","DOI":"10.1038\/s41598-021-97970-5","article-title":"Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement","volume":"11","author":"Korhonen","year":"2021","journal-title":"Sci Rep"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.2337\/dc20-0553","article-title":"Opposing associations of NT-proBNP with risks of diabetes and diabetes-related complications","volume":"43","author":"Birukov","year":"2020","journal-title":"Diabetes Care"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1073\/pnas.88.2.617","article-title":"Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro","volume":"88","author":"Rymaszewski","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ghir.2018.02.002","article-title":"Somatolactogens and diabetic retinopathy","volume":"41","author":"Bermea","year":"2018","journal-title":"Growth Horm IGF Res"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"935796","DOI":"10.3389\/fendo.2022.935796","article-title":"REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1900\/RDS.2020.16.24","article-title":"Insulin-like growth factor and its therapeutic potential for diabetes complications\u2014mechanisms and metabolic links: a review","volume":"16","author":"Biadgo","year":"2020","journal-title":"Rev Diabet Stud"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.kint.2022.04.022","article-title":"Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes","volume":"102","author":"Kobayashi","year":"2022","journal-title":"Kidney Int"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med Res Rev"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.0503021102","article-title":"Carbonic anhydrase XIV is enriched in specific membrane domains of retinal pigment epithelium, Muller cells, and astrocytes","volume":"102","author":"Nagelhus","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/hmg\/ddi023","article-title":"Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration","volume":"14","author":"Yang","year":"2005","journal-title":"Hum Mol Genet"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaut.2009.02.001","article-title":"Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy","volume":"32","author":"Adamus","year":"2009","journal-title":"J Autoimmun"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1534","article-title":"Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation","volume":"13","author":"Gao","year":"2007","journal-title":"Nat Med"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.51329\/mehdiophthal1443","article-title":"Carbonic anhydrase inhibitors in the management of macular edema: a review of the literature","volume":"11","author":"Shahsuvaryan","year":"2022","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1096\/fj.201700485rr","article-title":"Carbonic anhydrase III protects osteocytes from oxidative stress","volume":"32","author":"Shi","year":"2018","journal-title":"FASEB J"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br J Cancer"},{"issue":"11","key":"bib45","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3390\/ijms22116098","article-title":"Inhibition of carbonic anhydrase IX promotes apoptosis through intracellular pH level alterations in cervical cancer cells","volume":"22","author":"Temiz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2165\/00002512-199710050-00006","article-title":"Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension","volume":"10","author":"Balfour","year":"1997","journal-title":"Drugs Aging"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.18240\/ijo.2021.09.18","article-title":"Efficacy of topical dorzolamide 2% in diabetic cystoid macular edema","volume":"14","author":"Badawi","year":"2021","journal-title":"Int J Ophthalmol"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/IAE.0b013e3182215ae9","article-title":"Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia","volume":"32","author":"Genead","year":"2012","journal-title":"Retina"},{"issue":"2","key":"bib50","first-page":"4751","article-title":"Topical carbonic anhydrase inhibitor might be essential treatment in established diabetic retinopathy","volume":"20","author":"Alged","year":"2020","journal-title":"Biochem Cell Arch"},{"key":"bib51","first-page":"1003","article-title":"Interleukin 6 has a critical role in diabetes-induced retinal vascular inflammation and permeability","volume":"52","author":"Rojas","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00417-014-2586-6","article-title":"Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy","volume":"252","author":"Song","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib6","volume-title":"Diabetic retinopathy","author":"Shukla","year":"2025"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.1.47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:20Z","timestamp":1791927140000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.1.47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.1.47","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}